LESAKA TECHNOLOGIES, INC.
Unaudited Condensed Consolidated Statements of Cash Flows
7
Three months ended
September 30,
2024
2023
(In thousands)
Cash flows from operating activities
Net loss
$
(4,542)
$
(5,651)
Depreciation and amortization
6,276
5,856
Movement in allowance for doubtful accounts receivable and finance loans receivable
1,499
1,525
(Earnings) Loss from equity-accounted investments (Note 5)
(27)
1,405
Movement in allowance for doubtful loans to equity-accounted investments
-
(250)
Fair value adjustment related to financial liabilities
190
(34)
Interest payable
1,693
1,764
Facility fee amortized
69
227
Profit on disposal of property, plant and equipment
(27)
(36)
Stock-based compensation charge (Note 12)
2,377
1,759
Decrease (Increase) in accounts receivable and other receivables
7,692
(2,345)
Increase in finance loans receivable
(1,590)
(488)
Increase in inventory
(889)
(479)
(Decrease) Increase in accounts payable and other payables
(17,177)
375
Increase in taxes payable
765
308
Decrease in deferred taxes
(446)
(562)
Net cash (used in) provided by operating activities
(4,137)
3,374
Cash flows from investing activities
Capital expenditures
(3,965)
(2,809)
Proceeds from disposal of property, plant and equipment
850
284
Acquisition of intangible assets
(173)
(135)
Net change in settlement assets
3,570
(11,237)
Net cash provided by (used in) investing activities
282
(13,897)
Cash flows from financing activities
Proceeds from bank overdraft (Note 8)
23,893
59,574
Repayment of bank overdraft (Note 8)
(31,028)
(62,793)
Long-term borrowings utilized (Note 8)
774
2,471
Repayment of long-term borrowings (Note 8)
(5,472)
(2,629)
Proceeds from exercise of stock options
-
21
Net change in settlement obligations
(3,648)
10,696
Net cash (used in) provided by financing activities
(15,481)
7,340
Effect of exchange rate changes on cash
3,226
(443)
Net decrease in cash, cash equivalents and restricted cash
(16,110)
(3,626)
Cash, cash equivalents and restricted cash – beginning of period
65,919
58,632
Cash, cash equivalents and restricted cash – end of period (Note 14)
$
49,809
$
55,006
See Notes to Unaudited Condensed Consolidated Financial Statements